958358-00-4 Usage
Uses
Used in Pharmaceutical Industry:
1H-Pyrrolo[2,3-b]pyridine, 5-bromo-6-methylis used as a synthetic building block for the development of new drugs. Its unique structure allows for the creation of a variety of biologically active compounds, which can be further optimized for therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, 1H-Pyrrolo[2,3-b]pyridine, 5-bromo-6-methylserves as a key intermediate in the synthesis of agrochemicals. Its incorporation into these products can lead to the development of novel pesticides or other agricultural chemicals with improved efficacy and selectivity.
Used in Organic Chemistry Research:
1H-Pyrrolo[2,3-b]pyridine, 5-bromo-6-methylis utilized as a research tool in organic chemistry. Its distinctive molecular features make it suitable for studying various chemical reactions and mechanisms, contributing to the advancement of synthetic methodologies and the understanding of molecular interactions.
Used in Drug Discovery:
1H-Pyrrolo[2,3-b]pyridine, 5-bromo-6-methylis employed in drug discovery processes, where its structural attributes can be leveraged to design and develop new pharmaceutical agents. Its potential applications in this field include the creation of lead compounds and the exploration of novel therapeutic targets.
Check Digit Verification of cas no
The CAS Registry Mumber 958358-00-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,8,3,5 and 8 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 958358-00:
(8*9)+(7*5)+(6*8)+(5*3)+(4*5)+(3*8)+(2*0)+(1*0)=214
214 % 10 = 4
So 958358-00-4 is a valid CAS Registry Number.
InChI:InChI=1/C8H7BrN2/c1-5-7(9)4-6-2-3-10-8(6)11-5/h2-4H,1H3,(H,10,11)
958358-00-4Relevant academic research and scientific papers
INDOLE DERIVATIVES
-
Page/Page column 89, (2008/06/13)
The invention concerns indole derivatives of Formula (I) or pharmaceutically-acceptable salts thereof, wherein each of Ring A, m, R1, R2, n, R3 and G1 has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in therapy, for example in the treatment of disease mediated by a PI3K enzyme and/or a mTOR kinase.
